invoX Pharma
Pharmaceutical ManufacturingEngland, United Kingdom201-500 Employees
invoX Pharma is a research-driven global biopharmaceutical company and our mission is to improve lives by creating access to innovative medicines. We use next-generation technology platforms that take clinically validated approaches and incorporate innovative and novel features. This enables us to discover and develop potential therapies against promising targets. Our diversified pipeline consists of both clinical- and pre-clinical-stage programmes that address the unmet needs of patients globally and our R&D activities are focused in two areas. In Oncology R&D, we develop immuno-oncology therapies using proprietary technology that can be applied to a wide range of cancers. Our pipeline includes three bispecific antibodies in clinical development and multiple additional projects in preclinical development. In Respiratory R&D, our Respiratory Innovation Centre has developed a highly effective soft mist inhalation device which delivers medication to the lungs more effectively than powder or spray inhalers. We are using this to develop drug-device combination products for respiratory diseases. Incorporated in March 2021, we have R&D, Clinical Development and Business Development activities in the UK, EU and US.